Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size
- PMID: 11592984
- PMCID: PMC60106
- DOI: 10.1073/pnas.221445298
Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size
Abstract
CD1d-restricted natural killer (NK) T cells reactive with the glycolipid alpha-galactosylceramide (alpha-GalCer) are a distinct lymphocyte sublineage. They express an invariant Valpha14-Jalpha18 T cell receptor (TcR), but the role of the beta chain has been controversial. Here, we have used CD1d tetramers to identify and isolate NK T cells based on their antigen specificity. In mice lacking germline Vbeta8, most of the alpha-GalCer-reactive T cells express either Vbeta2 or Vbeta7, strong Vbeta selection being revealed by the lack of an increase in other Vbeta regions. By contrast to the selection for complementarity determining region (CDR) 3beta sequences in some anti-peptide responses, alpha-GalCer-reactive T cells have polyclonal CDR3beta sequences. There is little CDR3beta sequence redundancy between organs or individual mice, and, surprisingly, there also is no evidence for organ-specific CDR3beta sequence motifs. These data argue against a T cell receptor-mediated self-reactivity for tissue-specific CD1d-bound ligands. Each NKT clone is represented by only 5-10 cells. This clone size is similar to naive conventional T cells, and much lower than that reported for memory T cells, although NK T cells have an activated/memory phenotype.
Figures
Similar articles
-
The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.J Immunol. 2006 Jun 15;176(12):7447-55. doi: 10.4049/jimmunol.176.12.7447. J Immunol. 2006. PMID: 16751390
-
CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.J Immunol. 2005 Nov 15;175(10):6537-50. doi: 10.4049/jimmunol.175.10.6537. J Immunol. 2005. PMID: 16272308
-
Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.J Immunol. 2003 Mar 1;170(5):2390-8. doi: 10.4049/jimmunol.170.5.2390. J Immunol. 2003. PMID: 12594262
-
The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.Front Immunol. 2019 Jun 25;10:1449. doi: 10.3389/fimmu.2019.01449. eCollection 2019. Front Immunol. 2019. PMID: 31293596 Free PMC article. Review.
-
Regulation of immune responses by CD1d-restricted natural killer T cells.Immunol Res. 2004;30(2):139-53. doi: 10.1385/IR:30:2:139. Immunol Res. 2004. PMID: 15477656 Review.
Cited by
-
Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents.Clin Transl Immunology. 2016 Apr 8;5(4):e69. doi: 10.1038/cti.2016.14. eCollection 2016 Apr. Clin Transl Immunology. 2016. PMID: 27195112 Free PMC article. Review.
-
A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.J Exp Med. 2006 Mar 20;203(3):661-73. doi: 10.1084/jem.20051777. Epub 2006 Feb 27. J Exp Med. 2006. PMID: 16505140 Free PMC article.
-
Disposal of iNKT cell deficiency and an increase in expression of SLAM signaling factors characterizes sarcoidosis remission: a 4-year longitudinal study.Respir Res. 2014 Aug 21;15(1):91. doi: 10.1186/s12931-014-0091-4. Respir Res. 2014. PMID: 25142143 Free PMC article.
-
Optimizing NKT cell ligands as vaccine adjuvants.Immunotherapy. 2014;6(3):309-20. doi: 10.2217/imt.13.175. Immunotherapy. 2014. PMID: 24762075 Free PMC article. Review.
-
Extrinsic allospecific signals of hematopoietic origin dictate iNKT cell lineage-fate decisions during development.Sci Rep. 2016 Jun 29;6:28837. doi: 10.1038/srep28837. Sci Rep. 2016. PMID: 27354027 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
